Misdiagnosed follicular adenoma with 11 year postoperative liver and lung metastases a case report and literature review

As the second most common thyroid cancer, the follicular form has a good prognosis, but it is easily confused with follicular adenoma pre-operatively, which often leads to misdiagnosis, delayed treatment, and an increased risk of hematogenous metastasis. The optimization of diagnostic and treatment strategies is crucial for increasing the early diagnosis rate and improving the prognosis. A 73-year-old male was misdiagnosed as "follicular adenoma" 11 years previously and the left thyroid adenoma was resected. He was admitted with a confirmed diagnosis of follicular thyroid cancer and multiple metastases to the liver and lungs. A total resection of the left residual thyroid and the right thyroid and isthmus was performed, combined with bilateral central lymph node dissection, and post-operatively, two 131I-NaI 100 mCi treatments for the metastatic foci in the liver and lungs were administered, as well as regularly receiving oral levothyroxine replacement therapy. The one-year follow-up showed no recurrence of the primary foci and a significant reduction in metastatic foci, confirming the effectiveness of the comprehensive treatment program. Pre-surgery, follicular thyroid carcinoma is easily confused with follicular adenoma and nodular goiter with non-invasive encapsulated follicular tumors with papillary carcinoma nuclei, and it requires standardized treatment and detection of metastatic foci. Surgery combined with radioiodine is the mainstay of treatment and it is supplemented with levothyroxine replacement therapy. Targeted drugs are available for patients, refractory to radiotherapy. Long-term follow-up is essential to improve the prognosis.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-12-31
DOI
https://doi.org/10.1007/s12672-025-04096-5
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Misdiagnosed follicular adenoma with 11 year postoperative liver and lung metastases a case report and literature review

Hengtong Han, Ze Yang, Yongxun Zhao, Li-Bin Ma et al.
Discover Oncology
Thyroid Cancer Diagnosis and Treatment
article

Misdiagnosed follicular adenoma with 11 year postoperative liver and lung metastases a case report and literature review

Hengtong Han, Ze Yang, Yongxun Zhao, Li-Bin Ma, Kai-Li Yang, Shou-Hua Li, Xiao-Xiao Li
article en

Abstract

As the second most common thyroid cancer, the follicular form has a good prognosis, but it is easily confused with follicular adenoma pre-operatively, which often leads to misdiagnosis, delayed treatment, and an increased risk of hematogenous metastasis. The optimization of diagnostic and treatment strategies is crucial for increasing the early diagnosis rate and improving the prognosis. A 73-year-old male was misdiagnosed as "follicular adenoma" 11 years previously and the left thyroid adenoma was resected. He was admitted with a confirmed diagnosis of follicular thyroid cancer and multiple metastases to the liver and lungs. A total resection of the left residual thyroid and the right thyroid and isthmus was performed, combined with bilateral central lymph node dissection, and post-operatively, two 131I-NaI 100 mCi treatments for the metastatic foci in the liver and lungs were administered, as well as regularly receiving oral levothyroxine replacement therapy. The one-year follow-up showed no recurrence of the primary foci and a significant reduction in metastatic foci, confirming the effectiveness of the comprehensive treatment program. Pre-surgery, follicular thyroid carcinoma is easily confused with follicular adenoma and nodular goiter with non-invasive encapsulated follicular tumors with papillary carcinoma nuclei, and it requires standardized treatment and detection of metastatic foci. Surgery combined with radioiodine is the mainstay of treatment and it is supplemented with levothyroxine replacement therapy. Targeted drugs are available for patients, refractory to radiotherapy. Long-term follow-up is essential to improve the prognosis.

Discover OncologyVol. 17(1)
First Hospital of Lanzhou University (CN), Lanzhou University (CN)
Good health and well-being
Openalex Percentile: Top 29%
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.